Ghazawi Ibtisam, Cutler Samuel J, Low Pauline, Mellick Albert S, Ralph Stephen J
Genomics Research Centre, School of Health Science, Griffith University Gold Coast Campus, Gold Coast Mail Centre, PMB50, Queensland, 9726, Australia.
J Interferon Cytokine Res. 2005 Feb;25(2):92-102. doi: 10.1089/jir.2005.25.92.
Luciferase reporter constructs are widely used for analysis of gene regulation when characterizing promoter and enhancer elements. We report that the recently developed codon-modified Renilla luciferase construct included as an internal standard for cotransfection must be used with great caution with respect to the amount of DNA transfected. Also, the dual-luciferase reporter vectors encoding Photinus pyralis firefly or Renilla reniformis luciferase showed a linear increase in dose-response with increasing amounts of transfected DNA, but at higher levels of transfected DNA, a reduction in expressed levels of luciferase activity resulted. In addition, treatment with type I interferon (IFN) was found to significantly reduce levels of P. pyralis firefly and Renilla luciferase activity. In contrast, cells transfected with a green fluorescent protein (GFP) reporter construct showed no significant IFN-associated change. The reduction in luciferase activity resulting from IFN treatment was not due to IFN-mediated cytotoxicity, as no change in cellular propidium iodide (PI) staining was observed by flow cytometry. IFN treatment did not alter the levels of firefly luciferase activity in cell culture supernatants or the luciferase mRNA levels determined by quantitative real-time RT-PCR analysis. Based on these results, it is probable that the IFN-induced reduction in levels of luciferase activity detected in reporter assays occurs via a posttranscriptional mechanism. Thus, it is important to be aware of these complications when using luciferase reporter systems in general or for analyzing cytokine-mediated responsive regulation of target genes, particularly by the type I IFNs.
在对启动子和增强子元件进行表征时,荧光素酶报告基因构建体被广泛用于基因调控分析。我们报告称,最近开发的经密码子修饰的海肾荧光素酶构建体作为共转染的内标,在转染DNA的用量方面必须极其谨慎地使用。此外,编码萤火虫荧光素酶或海肾荧光素酶的双荧光素酶报告载体随着转染DNA量的增加,剂量反应呈线性增加,但在较高水平的转染DNA时,荧光素酶活性的表达水平会降低。另外,发现用I型干扰素(IFN)处理会显著降低萤火虫荧光素酶和海肾荧光素酶的活性水平。相比之下,用绿色荧光蛋白(GFP)报告基因构建体转染的细胞未显示出与IFN相关的显著变化。IFN处理导致的荧光素酶活性降低并非由于IFN介导的细胞毒性,因为通过流式细胞术未观察到细胞碘化丙啶(PI)染色的变化。IFN处理并未改变细胞培养上清液中萤火虫荧光素酶的活性水平,也未改变通过定量实时RT-PCR分析测定的荧光素酶mRNA水平。基于这些结果,在报告基因检测中检测到的IFN诱导的荧光素酶活性水平降低很可能是通过转录后机制发生的。因此,在一般使用荧光素酶报告系统或分析细胞因子介导的靶基因反应性调控时,尤其是由I型IFN介导的调控时,意识到这些复杂情况很重要。